In contrast, although tumor mutational burden (TMB) is high in SCLC, the lack of antigen presentation, immunosuppressive pattern in the stroma, and low expression of PD‐L1 make the lower immunogenic T‐cell profile of SCLC less likely to be as responsive as NSCLC.23 The gene discussed is CD274; the disease is neoplasm.